Literature DB >> 12118366

Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.

Olivier Ferrigno1, François Lallemand, Franck Verrecchia, Sébastien L'Hoste, Jacques Camonis, Azeddine Atfi, Alain Mauviel.   

Abstract

Members of the TGF-beta family of growth factors signal from the cell surface through serine/threonine kinase receptors. Intracellular propagation of the signal occurs by phosphorylation of intracellular proteins of the Smad family. Smad7 belongs to the subclass of inhibitory Smads that function as antagonists of TGF-beta signaling. A yeast two-hybrid screen of a human placental cDNA expression library using full-length mouse Smad7 as bait identified Yes-Associated Protein (YAP65) as a novel Smad7-interacting protein. The association of Smad7 with YAP65 was confirmed using co-expressed tagged proteins in COS-7 cells. Deletion of the PY motif of Smad7 reduced but did not abolish YAP65-Smad7 association, suggesting the existence of several interacting domains. We demonstrate that YAP65 potentiates the inhibitory activity of Smad7 against TGF-beta-induced, Smad3/4-dependent, gene transactivation. Furthermore, YAP65 augments the association of Smad7 to activated TGF-beta receptor type I (TbetaRI), whereas YAP65(1-301), which exerts a dominant-negative effect against Smad7-driven inhibition of TGF-beta signaling, reduces these interactions. Together, these data provide the first evidence that YAP65 is a Smad7 partner that facilitates the recruitment of the latter to activated TbetaRI, and enhances the inhibitory activity of Smad7 against TGF-beta signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118366     DOI: 10.1038/sj.onc.1205623

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  85 in total

1.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

Review 2.  Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.

Authors:  Christopher D Kegelman; Joseph M Collins; Madhura P Nijsure; Emily A Eastburn; Joel D Boerckel
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

Review 3.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

4.  YAP and TAZ are distinct effectors of corneal myofibroblast transformation.

Authors:  Santoshi Muppala; Vijay Krishna Raghunathan; Iman Jalilian; Sara Thomasy; Christopher J Murphy
Journal:  Exp Eye Res       Date:  2018-12-19       Impact factor: 3.467

5.  The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.

Authors:  Lin Zhang; Shuping Yang; Xingcheng Chen; Seth Stauffer; Fang Yu; Subodh M Lele; Kai Fu; Kaustubh Datta; Nicholas Palermo; Yuanhong Chen; Jixin Dong
Journal:  Mol Cell Biol       Date:  2015-02-02       Impact factor: 4.272

Review 6.  Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.

Authors:  J Wang; J F Martin
Journal:  J Dent Res       Date:  2017-07-12       Impact factor: 6.116

7.  Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.

Authors:  Ana Sebio; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

Review 8.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

Review 9.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17

10.  Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

Authors:  Daizo Koinuma; Masahiko Shinozaki; Akiyoshi Komuro; Kouichiro Goto; Masao Saitoh; Aki Hanyu; Masahito Ebina; Toshihiro Nukiwa; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.